NEMBUTAL ORAL LIQUIDS - AN OVERVIEW

pentobarbital will minimize the extent or result of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic influence of elbasvir/grazoprevir may very well be reduced if coadministered with potent CYP3A inducers which is consequently contraindicated.pentobarbital decreases levels of vandetanib